Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 1 May 2015

Nagarajah James, Ho Alan L, Tuttle R Michael, Weber Wolfgang A, Grewal Ravinder K

Abstract excerpt

UNLABELLED: There is significant interest in a better understanding of the genetic underpinnings of the increased glucose metabolic rates of cancer cells. Thyroid cancer demonstrates a broad variability of (18)F-FDG uptake as well as several well-characterized oncogenic mutations. In this study, we evaluated the differences in glucose metabolism of the BRAF(V600E) mutation versus BRAF wild-type (BRAF-WT) in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose

Share to Neoplasm Staging

Share to Positron-Emission Tomography

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 25814520
DOI: 10.2967/jnumed.114.150607
PMCID: PMC4970467

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study.PMID 25814520Read ↗

THE RELATIONSHIP OF BRAFV600E MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS.Semantic proximity Read ↗

Glucose Metabolic Reprogramming in Thyroid Cancer: Underlying Molecular Mechanisms and Links to Progression and Treatment.Semantic proximity Read ↗

Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer.Semantic proximity Read ↗

Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancerSemantic proximity Read ↗

The BRAF V600E mutation in papillary thyroid carcinoma is associated with glucose transporter 1 overexpression.Semantic proximity Read ↗

Clinico-pathological factors and 18 F-FDG PET/CT metabolic parameters for prediction of progression-free survival in Radioiodine Refractory Differentiated Thyroid CarcinomaSemantic proximity Read ↗

Targeting the Warburg Effect in Anaplastic and Poorly Differentiated Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic OpportunitiesSemantic proximity Read ↗

Correlation of BRAF mutation and SUVmax levels in thyroid cancer patients incidentally detected in 18F-fluorodeoxyglucose positron emission tomography.Semantic proximity Read ↗

BRAFV600E/p-ERK/p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer.Semantic proximity Read ↗

Relationship Between 18F-fluorodeoxyglucose Accumulation and the BRAF V600E Mutation in Papillary Thyroid Cancer.Semantic proximity Read ↗

Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer.Semantic proximity Read ↗

FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.